Charles N. Mills - 16 Dec 2025 Form 4 Insider Report for Medline Inc. (MDLN)

Reporting relationship: Director
Issuer ticker: MDLN
Reported as of: 16 Dec 2025
Net transaction value: +$74,799,990
SEC form: 4
Accepted by SEC: 22 Dec 2025, 16:30:04 UTC
Next SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Nicole Fritz, Attorney-in-Fact

Key filing fact

Charles N. Mills filed Form 4 for Medline Inc. (MDLN) on 22 Dec 2025.

Key facts

This page summarizes Charles N. Mills's Form 4 filing for Medline Inc. (MDLN).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Dec 2025, 16:30.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$74,799,990.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001460221 Primary reporting owner

Mills Charles N.

Relationship: Director
Address: C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
Signature: /s/ Nicole Fritz, Attorney-in-Fact
Signature date: 22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN transaction

Class B Common Stock

Award

Transaction value
Shares: +64,005
Change %
Price
Shares after: 64,005
Date: 16 Dec 2025
Ownership: See Footnote
Footnotes: F1, F2

MDLN transaction

Class A Common Stock

Purchase

Transaction value: $70,799,991
Shares: +2,441,379
Change %
Price: $29.00
Shares after: 2,441,379
Date: 18 Dec 2025
Ownership: See Footnote
Footnotes: F3, F4

MDLN transaction

Class A Common Stock

Purchase

Transaction value: $3,999,999
Shares: +137,931
Change %
Price: $29.00
Shares after: 137,931
Date: 18 Dec 2025
Ownership: By Spouse
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDLN transaction Derivative

Common Units of Medline Holdings, LP

Award

Transaction value
Shares: +64,005
Change %
Price
Shares after: 64,005
Date: 16 Dec 2025
Ownership: See Footnote
Underlying class: Class A Common Stock
Underlying amount: 64,005
Exercise price
Footnotes: F1, F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.

Footnote F2

These securities are held by a trust for the benefit of the Reporting Person and for which the Reporting Person serves as a trustee.

Footnote F3

Reflects shares of Class A Common Stock of the Issuer acquired in the initial public offering of Class A Common Stock of the Issuer at the initial public offering price and on the same terms as the other purchasers in the initial public offering.

Footnote F4

The securities are held for the benefit of the Reporting Person by a limited liability company.

Footnote F5

Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP for shares of the Issuer's Class A common stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.